3 completed, 1 withdrawn. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Nordic Nanovector: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL 10 MBq/kg Betalutin, 15 MBq/kg Betalutin - Non Hodgkin Lymphoma, Follicular Lymphoma | Phase 1 | Completed | Nordic Nanovector | 7 | 2018-10-04 | 2023-12-22 |
| Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02) Betalutin with lilotomab dose 1, Betalutin with lilotomab dose 2 - Non-Hodgkin Lymphoma | Phase 1 | Withdrawn | Nordic Nanovector | 2017-12-19 | 2019-01-10 | |
| Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05) Betalutin - Relapsed, Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 1 | Completed | Nordic Nanovector | 18 | 2017-03-02 | 2024-01-16 |
| A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma 10 MBq/kg Betalutin, 15 MBq/kg Betalutin, 20 MBq/kg Betalutin - Non-Hodgkin Lymphoma, Follicular Lymphoma | Phase 1 / Phase 2 | Completed | Nordic Nanovector | 191 | 2012-12-01 | 2024-06-21 |
Lymphoma, Non-Hodgkin (4) · Lymphoma, Follicular (3) · AIDS-Related Complex (2) · Immune System Diseases (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Immunoproliferative Disorders (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Recurrence (1)
Lutetium (2) · tetulomab tetraxetan lu-177 (2) · Lutetium-177 (1) · Rituximab (1)
Czechia (2) · Germany (2) · Italy (2) · Norway (2) · Spain (2) · United Kingdom (2) · United States (2) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Croatia (1) · Denmark (1) · Finland (1) · France (1)
Andreas Buck, Prof. MD (1) · Chris Freitag (1) · Timothy Illidge, PhD MB BS (1)
PMID 32877524, PMID 33196921, PMID 41754790
2017 (1)